【Genmont】February 2026 Monthly Revenue NT$0.16 Billion (YoY -35.5%)
NQ Score
47/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Genmont Biotechnology announced its February 2026 monthly revenue was NT$0.16 billion, a year-on-year decrease of 35.5%. This biomedical company specializes in probiotic products, and its monthly revenue data reflects the current market sales conditions and challenges it faces.
AI analysis data is not yet available.